Iodine or Iodide? A Laboratory Evaluation of the Content of ­Powdered Iodine Supplements
Darrow Hand, ND
Denis Wilson, MD
PDF
HTML

Keywords

Iodide
Iodine
Iodine supplementation
Thyroid hormones
PDF
HTML

Abstract

Background: Iodine is a vital micronutrient essential for thyroid hormone synthesis and neurological development in utero and in the early postpartum period. Maternal iodine deficiency during pregnancy can result in infant congenital hypothyroidism. Congenital hypothyroidism is the most prevalent preventable cause of mental retardation in the world. Some proponents of supplementation believe that products containing both iodine (I2) and iodide (I) are therapeutically superior to iodide-only formulations. As a step toward evaluating this claim, we tested three commercially available products that list both iodine and iodide on the label, to determine their content.

Design: Two powdered and one aqueous solution were tested using ion chromatography, X-ray spectrometry, ion coupled mass spectrometry, and the iodine-starch test to more accurately determine their composition.

Results: We found that when each of the dry supplements were dissolved in a slightly basic solution, only the I form was then present.

Conclusion: Our findings suggest that dry products made with only iodide are likely to be substantially equivalent to dry products made with both forms, at least by the time they are digested and absorbed.

PDF
HTML

References

Haddow JE, Glenn MD, Palomaki GE, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341:549–55.
Leung AM, Pearce EN, Braverman LE. Iodine nutrition in pregnancy and lactation. Endocrinol Metab Clin North Am. 2011; 40:765–77.
Markel H. “When it rains it pours”: endemic goiter, iodized salt, and David Murray Cowie, M.D. Am J Public Health. 1987; 77:219–29.
Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States: trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994). J Clin Endocrinol Metab. 1998; 83:3401–8.
Costa A, Testori OB, Cenderelli C, et al. Iodine content of human tissues after administration of iodine containing drugs or contrast media. J Endocrinol Invest. 1978; 1:221–5.
Ahad F, Ganie SA. Iodine, iodine metabolism and iodine deficiency disorders revisited. Indian J Endocrinol Metab. 2010; 14:13–7.
World Health Organization. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers, 3rd edn. Geneva (Switzerland): World Health Organization; 2007 (WHO/NHD/01.1) [cited 2017]. Available from: http://apps.who.int/iris/bitstream/10665/43781/1/9789241595827_eng.pdf
Centers for Disease Control and Prevention. Trace Elements: Iodine. Available from: https://www.cdc.gov/nutritionreport/99-02/pdf/nr_ch4a.pdf Accessed August 11, 2017.
Zava TT, Zava DT. Assessment of Japanese iodine intake based on seaweed consumption in Japan: a literature-based analysis. Thyroid Res. 2011; 4:14. doi: doi: https://doi.org/10.1186/1756-6614-4-14.
Cann SA, van Netten JP, van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control. 2000; 11:121–7.
National Institute of Health, Office of Dietary Supplements. Iodine: Fact Sheet for Health Professionals. Available from: https://ods.od.nih.gov/factsheets/Iodine-HealthProfessional/ Accessed August 11, 2017.
Hou X. Iodine speciation in foodstuff, tissues and environmental samples: iodine species and analytical methods. In: Preedy VR, Burrow GN, Watson RR, eds. Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological, and Therapeutic Aspects. Boston: Academic Press; 2009. pp. 139–50.
Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I− symporter (NIS): mechanism and medical impact. Endocr Rev. 2014; 35:106–49. doi: doi: https://doi.org/10.1210/er.2012-1036.
Riesco-Eizaguirre G, Leoni SG, Mendiola M, et al. NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. J Clin Endocrinol Metab. 2014; 99:E1199–208.
Russo D, Scipioni A, Durante C, et al. Expression and localization of the sodium/iodide symporter (NIS) in testicular cells. Endocrine. 2011; 40:35–40.
Mitchell AM, Manley SW, Morris JC, et al. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta. 2001; 22:256–8.
Paulev PE, Zubieta-Calleja G. Thyroid hormones and disorders. In: Textbook in Medical Physiology and Pathophysiology Essentials and Clinical Problems, 2nd edn. http://www.zuniv.net/physiology/book Accessed July 14, 2017.
Bretthauer EW. Milk transfer comparisons of different chemical forms of radioiodine. Health Phys. 1972; 22:257–60.
Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1980; 60:1049–106.
Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia. 2005; 10:189–96.
Taurog A. Hormone synthesis: thyroid iodine metabolism. In: Braverman L, Utiger RD, eds. Werner and Ingbar’s The Thyroid. Philadelphia: Lippincott; 1996. pp. 47–81.
Shah NM, Eskin BA, Krouse TB, Sparks CE. Iodoprotein formation by rat mammary glands during pregnancy and early post-partum period. Proc Soc Exp Biol Med. 1986; 181:443–9.
Patrick L. Iodine: deficiency and therapeutic considerations. Altern Med Rev. 2008; 13:116–27.
Thrall KD, Bull RJ. Differences in the distribution of iodine and iodide in the Sprague–Dawley rat. Fundam Appl Toxicol. 1990; 15:75–81.
Thrall KD, Sauer RL, Bull RJ. Evidence for thyroxine formation following iodine administration in Sprague–Dawley rats. J Toxicol Environ Health. 1992; 37:443–49.
García-Solís P, Alfaro Y, Anguiano B, et al. Inhibition of induced-MNU mammary carcinogenesis by molecular iodine (I2) but not by iodide (I−) treatment: evidence that I2 prevents cancer promotion. Mol Cell Endocrinol. 2005; 236;49–57.
Soriano O, Delgado G, Anguiano B, et al. Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: association between lactoperoxidase and estrogen-adduct production. Endocr Relat Cancer. 2011; 18:529–39.
Ghent WR, Eskin BA, Low DA, Hill LP. Iodine replacement in fibrocystic disease of the breast. Can J Surg. 1993; 36:453–60.
Preedy VR, Burrow GN, Watson RR, eds. Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological, and Therapeutic Aspects. Boston: Academic Press; 2009.
Ophardt CE. Starch – iodine. In: Virtual Chembook. Available from: http://chemistry.elmhurst.edu/vchembook/548starchiodine.html Accessed August 11, 2017.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.